Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 82 entries
View as:

Chlorhexidine Caps for CLABSI Prevention in Hemodialysis: a Pilot Randomized Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT07019610 Org: User:
Start: 08/31/25 End: 02/29/28 Due: 02/28/29

Finding the Optimal Regimen for Mycobacterium Abscessus Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04310930 Org: User:
Start: 03/02/20 End: 06/30/30 Due: 06/30/31

Pasteurised Donor Human Milk Supplementation for Term Babies

Phase: N/A Priority: Normal
NCT ID: NCT06993103 Org: User:
Start: 06/02/25 End: 12/31/28 Due: 12/31/29

Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT02709343 Org: User:
Start: 04/21/17 End: 10/25/23 Due: 10/25/24

Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT04643327 Org: User:
Start: 02/09/21 End: 12/31/25 Due: 12/31/26

Screening Anti-Fungal Exposure in Intensive Care Units

Phase: N/A Priority: Normal
NCT ID: NCT03136926 Org: User:
Start: 01/31/17 End: 12/31/18 Due: 12/31/19

A Clinical Study in the Use of Orthotics in Treating Pain in the Front of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT00118521 Org: User:
Start: 05/31/04 End: 06/30/07 Due: 06/30/08

The Effect of Urox™ in the Treatment of Overactive Bladder and Urinary Incontinence

Phase: N/A Priority: Normal
NCT ID: NCT02396160 Org: User:
Start: 08/31/13 End: 05/31/15 Due: 05/31/16

Prevention of Bronchiectasis in Infants With Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01270074 Org: User:
Start: 04/30/12 End: 03/31/21 Due: 03/31/22

RCT Cefiderocol vs BAT for Treatment of Gram Negative BSI

Phase: N/A Priority: Normal
NCT ID: NCT03869437 Org: User:
Start: 10/28/19 End: 01/29/24 Due: 01/29/25

The Effect of a Wearable Cueing Device on Freezing of Gait in Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02356536 Org: User:
Start: 10/31/13 End: 12/31/15 Due: 12/31/16

A Practice Change for Patients With Severe Chronic, Clinically Unexplained Gastrointestinal Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT05274854 Org: User:
Start: 05/01/23 End: 12/31/25 Due: 12/31/26

Association of MPOD Values With Blue Light.

Phase: N/A Priority: Normal
NCT ID: NCT04779398 Org: User:
Start: 09/25/20 End: 03/31/22 Due: 03/31/23

Protective Manual Hyperinflation in Acute Mechanically Ventilated Trauma Patients

Phase: N/A Priority: Normal
NCT ID: NCT01366274 Org: User:
Start: 09/30/07 End: 12/31/11 Due: 12/31/12

Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside

Phase: N/A Priority: Normal
NCT ID: NCT06324877 Org: User:
Start: 05/01/24 End: 10/30/25 Due: 10/30/26

Pharmacogenomics for Better Treatment of Fungal Infections in Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06510699 Org: User:
Start: 11/01/24 End: 09/02/26 Due: 09/02/27

Evaluation of a MCYI as Adjunct to Psychiatric Treatment for Vietnam Veterans With PTSD - RCT

Phase: N/A Priority: Normal
NCT ID: NCT00256464 Org: User:
Start: 06/30/07 End: 01/31/08 Due: 01/31/09

New Diagnostics in Neutropenia

Phase: N/A Priority: Normal
NCT ID: NCT05174546 Org: User:
Start: 01/10/23 End: 07/31/23 Due: 07/31/24

A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT04495933 Org: User:
Start: 07/13/20 End: 04/30/24 Due: 04/30/25

Vascular Access Outcome Measure for Function: a vaLidation Study In haemoDialysis

Phase: N/A Priority: Normal
NCT ID: NCT03969225 Org: User:
Start: 12/06/19 End: 02/17/23 Due: 02/17/24

STarting incrEmental Prescription of Peritoneal Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT06642597 Org: User:
Start: 03/01/25 End: 09/30/29 Due: 09/30/30

Using Lignocaine Spray and Gel to Reduce the Pain Associated With Nasogastric Tube Insertion in Children

Phase: N/A Priority: Normal
NCT ID: NCT01075789 Org: User:
Start: 05/31/10 End: 03/31/11 Due: 03/31/12

The SHIELD Whole Lung Lavage Study

Phase: N/A Priority: Normal
NCT ID: NCT05402176 Org: User:
Start: 06/30/22 End: 12/31/24 Due: 12/31/25

The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT04638517 Org: User:
Start: 09/07/21 End: 06/30/25 Due: 06/30/26

T2 and SeptiCyte RAPID Duration Project

Phase: N/A Priority: Normal
NCT ID: NCT04821661 Org: User:
Start: 01/11/22 End: 08/31/23 Due: 08/31/24